Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seelos Therapeutics Inc
(NQ:
SEEL
)
1.280
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seelos Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
May 16, 2023
Clinical-stage biopharma company Seelos Therapeutics Inc. (NASDAQ: SEEL) reported financial results and clinical updates corresponding to the first quarter ended March 31, 2023. Quarterly numbers...
Via
Benzinga
April Psychedelic Drug Stocks Recap: The Ups And Downs
April 30, 2023
Via
Talk Markets
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
April 21, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
April 20, 2023
Via
Benzinga
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
April 19, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2023
April 18, 2023
Via
Benzinga
Seelos Therapeutics Pauses Spinocerebellar Ataxia Study Citing Financial Considerations
March 30, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 17, 2023
April 17, 2023
Via
Benzinga
ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today
April 14, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2023
April 13, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 12, 2023
April 12, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2023
April 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 10, 2023
April 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 7, 2023
April 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 6, 2023
April 06, 2023
Via
Benzinga
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today
April 05, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 4, 2023
April 04, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
April 03, 2023
Via
Benzinga
Largest Psychedelic Stocks -3.4% In March
April 02, 2023
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 31, 2023
March 31, 2023
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
March 30, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2023
March 29, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 28, 2023
March 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
March 27, 2023
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via
Benzinga
Meta Platforms To Rally Over 32%? Here Are 10 Other Analyst Forecasts For Friday
March 24, 2023
TD Securities cut the price target for Lululemon Athletica Inc. (NASDAQ: LULU) from $488 to $470. TD Securities analyst John Kernan maintained an Outperform rating. Lululemon shares fell 0.5% to...
Via
Benzinga
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.